ACON

1.22213.94%
AW

Amanda Williams

Independent Director

Ms. Amanda Williams, also known as Amanda Sequira, served as Senior Vice President of Clinical, Quality and Regulatory at ViewRay, Inc. September 2018 until July 2023. She had served as Senior Vice President of Government Affairs & Market Access at ViewRay, Inc. since 2022 and served as its Senior Vice President of Clinical, Quality & Regulatory at ViewRay, Inc. since June 2021 until 2022. She joined ViewRay in October of 2018. She has been in various leadership roles across clinical, quality and regulatory with Philips Image Guided Therapy division, Spectrantics and AGA Medical (now part of Abbott). One of these studies achieved a first of its kind indication for use with the FDA for the U.S market. She serves as an Independent Director of Aclarion, Inc. (fka Nocimed, Inc.) since April 21, 2022. Ms. Williams has been Senior Vice President for Clinical and Regulatory at Med Alliance since August 2023. From December, 2017, to September, 2018, she was the Head of Regulatory with the Image Guided Therapy Devices and Systems divisions of Philips. From July, 2010 to December, 2017 Ms. Sequira was the Senior Director (2010-2013) and Vice President (2013-2017) of Clinical and Regulatory with The Spectranetics Corp., (now part of Philips) and from 2003 to 2010 she was Manager and then Director of Regulatory of AGA Medical Corporation(now part of Abbott). Prior to these roles, she worked as a Regulatory Specialist with Vascular Solutions and as a Chemist with GE – Osmonics. She holds a Masters of Science in Regulatory from Northeastern University and a Bachelors of Science in Chemistry from the University of Minnesota.

Positions